ResearcherJohns Hopkins UniversityActive in the last 2 years

Helena Saba

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-0973-9116; OpenAlex author ID A5051663630. Sources: OpenAlex.

Their work

Papers: 4 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 4

Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals. First author DOI 10.1016/j.gastha.2025.100802 ↗
Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. Co-author DOI 10.1200/jco.23.01573 ↗
Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-024-14942-5 ↗
Familial Pancreatic Cancer. Co-author DOI 10.1016/j.gtc.2022.06.006 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael Goggins · 4 shared papers, 2022–2025 · strength 0.95
Jin Peng He · 3 shared papers, 2024–2025 · strength 0.62
Amanda L. Blackford · 3 shared papers, 2024–2025 · strength 0.62
Richard Andrew Burkhart · 3 shared papers, 2024–2025 · strength 0.62
Elizabeth Abou Diwan · 3 shared papers, 2024–2025 · strength 0.62
Marcia Irene Canto · 2 shared papers, 2024–2025 · strength 0.42
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802 ↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573 ↗
Takeichi Yoshida · 2 shared papers, 2024 · strength 0.37
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5 ↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573 ↗
Yohei Ando · 2 shared papers, 2024 · strength 0.37
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5 ↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573 ↗
James R. Eshleman · 2 shared papers, 2024 · strength 0.37
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5 ↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573 ↗
Ralph H. Hruban MD · 1 shared paper, 2025 · strength 0.25
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802 ↗
Linda Chi Hang Chu · 1 shared paper, 2025 · strength 0.25
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802 ↗
Anne Marie Lennon · 1 shared paper, 2024 · strength 0.18
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.